Uncovering the Impact of HTA on Medical Device and Diagnostic Procurement Process and Outcomes: Insights and Discussion From the ISPOR Medical Devices and Diagnostics SIG Key Project Research


Moderator: Michael Joseph Cangelosi, MA, MPH, Boston Scientific, Natick, MA, USA
Speakers: Arturo Cabra, MSc, HEOR, GE Healthcare, Miami, FL, USA; Patricia Synnott, MS, MALD, Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA, USA; Meike Bomhof, MA, Avania, Valencia, V, Spain

Presentation Documents

Health Technology Assessments (HTAs) for MedTech often do not lead to a funding or reimbursement mandate despite being a very robust manner of technology evaluation. Initiatives such as value-based procurement, where the procurement decisions are made on clinical improvement and reduced total costs suggest HTA could be a very valuable resource for procurement decision making. The ISPOR Medical Devices and Diagnostics Special Interest Group (MD&D SIG) working group has undertaken and published a systematic review of literature describing how HTA is influencing and linked to procurement decisions. This project identified limited evidence that HTAs inform medical device procurement. Procurement decisions were often considered standard HTA factors but lacked transparency. The study advocates for increased transparency, research, and collaboration to better link HTA findings with procurement decisions, potentially leading to improved healthcare savings and accessibility. We will discuss these potential policy implications and the ongoing efforts of the ISPOR MD&D SIG working group to survey HTA and procurement stakeholders to understand in more depth the links between these groups and identify opportunities for closer collaboration. The panel will discuss the linkage between HTA and procurement of MedTech devices and diagnostics and policy implications to (1) support and inform ongoing ISPOR MD&D SIG working group actively surveying of HTA and procurement stakeholders and (2) extend an opportunity for ISPOR members to participate in this working group survey activity and (3) inform the survey questions.

Conference/Value in Health Info

2024-05, ISPOR 2024, Atlanta, GA, USA




Health Technology Assessment

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now